Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials
call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or
email cancerclinicaltrials@bsd.uchicago.edu.

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Diffuse Large B-cell Lymphoma (D4190C00023)

Official Title

A Phase 1b Study to Evaluate the Safety and Efficacy of MEDI4736 as Monotherapy and in Combination With Tremelimumab or AZD9150 in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Principal Investigator

Kline, Justin

Brief Summary

The purpose of this study is to evaluate the safety, tolerability, and efficacy of MEDI4736
alone and in combination with either tremelimumab or AZD9150 in adult subjects with relapsed
or refractory dIffuse large B-cell lymphoma.